维普期刊资源整合服务平台（V6.5）

156篇 您的检索式：作者名="HOLMES FA"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer 显示文摘	Walters RS Thierault RL	1991	J Natl Cancer Inst1991，83，24：	1
2	Comparable efficacy and safety profiles of once'per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia : a multicenterdose-finding study in women with breast cancer显示文摘	Holmes FA Jones SE O'Shaughnessy J	2002	Ann Oncol2002，13，6：	1
3	Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US oncology research trim 9735 显示文摘	Jones S Holmes FA O' Shaughnessy J	2009	J Clin 0ncol2009，27，：	1
4	Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer显示文摘	Miller KD Chap LI Holmes FA	2005	Clin Oncol2005，23，4：	1
5	Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubiein and Cyclophos- phamide: 7-Year Follow-Up of US Oneology Research Trial 9735显示文摘	Jones S Holmes FA O'Shaughnessy J	2009	J Clin Oncol2009，27，8：	1
6	Randomized phase Ⅲ trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer 显示文摘	Miller KD Chap LI Holmes FA	2005	J Clin Oncol2005，23，4：	1
7	Randomized phase Ⅲ trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer 显示文摘	Miller KD Chap LI Holmes FA	2005	J Clin Oncol2005，23，4：	1
8	Randomized phase trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer 显示文摘	Miller KD Chap LI Holmes FA	2005	J Clin Oncol2005，23，4：	1
9	Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy显示文摘	O'Shaughnessy JA Vukelja SJ Holmes FA	2005	Clin Breast Cancer2005，5，6：	1
10	Randomized phase Ⅲ trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer显示文摘	Miller KD Chap LI Holmes FA	2005	J Clin Oncol2005，23，4：	1
11	Management of breast cancer during pregnancy using a standardized protocol显示文摘	Berry DL Theriault RL Holmes FA	1999	J Clin Oncol1999，17，：	1
12	Docetaxel with cyclophosphamide is associated with an overal survival benefit compared to doxorubicin and cyclophosphamide:7-year followup of US Oncology Research Trial 9735显示文摘	Jones SE Holmes FA O'Shaughnessy JA	2009	J Clin Oncol2009，27，10：	1
13	Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer显示文摘	HOLMES FA JONES SE O'SHAUGHNESSY J	2002	Ann Oncol2002，13，6：	1
14	Docetraxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide:7-year follow-up of US oncology Research Trial 9735显示文摘	Jones S Holmes FA O'shaughnessy J	2009	J Chin Oncol2009，27，8：	1
15	Blinded,randomized,multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer显示文摘	HOLMES FA O'SHAUGHNESSY JA VUKELJA S	2002	J Clin Oncol2002，20，3：	1
16	Blinded, randomized, multieenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage Ⅱ or stage Ⅲ/Ⅳ breast cancer显示文摘	Holmes FA O' Shaughnessy JA Vukelja S	2002	J Clin Oncol2002，20，3：	1
17	Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia:a multicenter dose-finding study in women with breast cancer显示文摘	Holmes FA Jones SE O'Shaughnessy J	2002	Ann Oncol2002，13，6：	1
18	Randomized phaseⅢtrial ofcapecitabine compared with bevacizumab plus capecitabine in pa-tients with previously treated metastatic breast cancer显示文摘	Miller KD Chap LI Holmes FA	2005	J ClinOncol2005，23，4：	1
19	Blinded,randomized,multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer显示文摘	Holmes FA O'Shaughnessy JA Vukelja S	2002	J Clin Oncol2002，20，3：	1
20	Early child-hood development of late-preterm infants: a systematic re-view显示文摘	McGowan JE Alderdicc FA Holmes VA ei al	2011	127(6) :1111-11242011，127，6：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示